CIDARA THERAPEUTICS, INC. Revenue
CIDARA THERAPEUTICS, INC. reported Revenue of $0 for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Income Statement
us-gaap:Revenues · last filed 2025-11-06
- CIDARA THERAPEUTICS, INC. revenues for the quarter ending 2025-09-30 was $0.00.
- CIDARA THERAPEUTICS, INC. revenues for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- CIDARA THERAPEUTICS, INC. revenues for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- CIDARA THERAPEUTICS, INC. revenues for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- CIDARA THERAPEUTICS, INC. revenues for fiscal 2024 was $1.27M, a 94.52% decline from fiscal 2023.
- CIDARA THERAPEUTICS, INC. revenues for fiscal 2023 was $23.28M, a 63.87% decline from fiscal 2022.
- CIDARA THERAPEUTICS, INC. revenues for fiscal 2022 was $64.45M.
| Period end | Revenues 3 month | Revenues 3 month as first filed | Revenues 6 month | Revenues 6 month as first filed | Revenues 9 month | Revenues 9 month as first filed | Revenues 12 month | Revenues 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | $0.00 10-Q · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | $0.00 derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | $0.00 derived: sum of 3 quarters · filed 2025-08-07 | $0.00 derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | $0.00 derived: sum of 2 quarters · filed 2025-05-08 | $0.00 derived: sum of 3 quarters · filed 2025-11-06 | $302.00K derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $302.00K derived: sum of 3 quarters · filed 2025-11-06 | $1.27M 10-K · filed 2025-03-06 | ||||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-06 | $302.00K derived: sum of 2 quarters · filed 2025-11-06 | $1.27M 10-Q · filed 2025-11-06 | $4.03M derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | $302.00K 10-Q · filed 2025-08-07 | $1.27M 10-Q · filed 2025-08-07 | $4.03M derived: sum of 3 quarters · filed 2025-08-07 | $13.25M derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | $973.00K 10-Q · filed 2025-05-08 | $8.46M 10-Q · filed 2024-05-15 | $3.73M derived: sum of 2 quarters · filed 2025-05-08 | $12.95M derived: sum of 3 quarters · filed 2025-05-08 | $18.04M derived: sum of 4 quarters · filed 2025-05-08 | |||
| 2023-12-31 | $2.76M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $11.97M derived: sum of 2 quarters · filed 2025-03-06 | $17.06M derived: sum of 3 quarters · filed 2025-03-06 | $23.28M 10-K · filed 2025-03-06 | $63.91M 10-K · filed 2024-04-22 | |||
| 2023-09-30 | $9.22M 10-Q · filed 2024-11-07 | $12.72M 10-Q · filed 2023-11-02 | $14.31M derived: sum of 2 quarters · filed 2024-11-07 | $20.53M 10-Q · filed 2024-11-07 | $46.32M 10-Q · filed 2023-11-02 | $50.63M derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | $5.09M 10-Q · filed 2024-08-13 | $7.50M 10-K · filed 2024-04-22 | $11.31M 10-Q · filed 2024-08-13 | $33.60M 10-K · filed 2024-04-22 | $41.42M derived: sum of 3 quarters · filed 2024-08-13 | $82.16M derived: sum of 4 quarters · filed 2024-08-13 | ||
| 2023-03-31 | $26.11M 10-Q · filed 2024-05-15 | $36.33M derived: sum of 2 quarters · filed 2024-05-15 | $77.07M derived: sum of 3 quarters · filed 2024-05-15 | $83.29M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $10.22M derived: 10-K 12 month − 10-K 9 month · filed 2024-04-22 | $50.96M derived: sum of 2 quarters · filed 2024-04-22 | $57.18M derived: sum of 3 quarters · filed 2024-04-22 | $64.45M 10-K · filed 2024-04-22 | ||||
| 2022-09-30 | $40.74M 10-K · filed 2024-04-22 | $46.96M derived: sum of 2 quarters · filed 2024-04-22 | $54.23M 10-K · filed 2024-04-22 | $54.07M 10-Q · filed 2023-11-02 | ||||
| 2022-06-30 | $6.22M 10-K · filed 2024-04-22 | $13.48M 10-K · filed 2024-04-22 | ||||||
| 2022-03-31 | $7.27M 10-K · filed 2024-04-22 |